GLOW is a tri-peptide research blend supplied as a single lyophilized 70 mg vial containing BPC-157 (10 mg), TB-500 (10 mg), and GHK-Cu (50 mg). The blend is studied in preclinical research for the complementary signalling pathways engaged by its three constituents.

BPC-157 is a synthetic 15-amino-acid pentadecapeptide reported in preclinical literature to promote angiogenesis, modulate nitric oxide synthase activity and growth-factor signalling, and influence extracellular-matrix protein production and remodelling in gastrointestinal and tissue-response research models.

TB-500 is a synthetic analogue of thymosin β-4 studied for its role in cytoskeletal dynamics. It regulates actin polymerisation, facilitates cell migration, and up-regulates endothelial proliferation and capillary formation, contributing to angiogenesis in research models.

GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) studied for its role in gene-expression modulation and extracellular-matrix biology. Published research describes effects on the expression of genes governing matrix metalloproteinase activity, antioxidant-response pathways, and dermal-fibroblast signalling.

Sold for qualified laboratory and research purposes only. Not for human or animal consumption.